Dynex Capital Appoints Internal Veteran Michael Sartori as New CFO Amidst Smooth Transition
DX sits 30% above its 52-week low of $10.79.
Summary
Dynex Capital appointed Michael Sartori, its Head of Capital Markets, as the new CFO, succeeding Robert S. Colligan in a mutually agreed and smooth transition.
Key Events · Executive and Board Changes · DX
-
New Chief Financial Officer Appointed
Michael Sartori, previously Head of Capital Markets and FP&A, has been appointed as the new Chief Financial Officer, effective February 26, 2026.
-
Outgoing CFO's Departure and Transition
Robert S. Colligan mutually agreed to step down as CFO and will serve as a Special Advisor until May 1, 2026, to ensure a smooth transition. The departure is not due to any disagreements on financial reporting or practices.
-
New CFO's Compensation Package
Mr. Sartori received equity awards totaling $1.55 million, comprising $350,000 in Restricted Stock Units (RSUs) and $1,200,000 in Performance Stock Units (PSUs), vesting over three years.
-
Internal Promotion Signals Continuity
Mr. Sartori has been with Dynex Capital for over a decade, holding key roles in capital strategy and financial analysis, indicating a strategic internal promotion.
Analysis · DX · Real Estate & Construction
Dynex Capital, Inc. announced a planned transition in its Chief Financial Officer role, appointing Michael Sartori, a long-time company executive, to succeed Robert S. Colligan. Sartori's extensive background in capital markets and financial planning, cultivated over a decade with the company, positions him well to continue the firm's strategic financial initiatives, including recent successful capital raises. The mutually agreed-upon departure of Mr. Colligan, with no reported disagreements on financial matters and a transition advisory period, suggests a smooth leadership change during a period of strong financial performance for the company.
At the time of this filing, DX was trading at $14.00 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $2.8B. The 52-week trading range was $10.79 to $14.93. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.